Histone H1 kills MRSA
- PMID: 39546397
- DOI: 10.1016/j.celrep.2024.114969
Histone H1 kills MRSA
Abstract
The antimicrobial activity of histones was discovered in the 1940s, but their mechanism of action is not fully known. Here we show that methicillin-resistant Staphylococcus aureus (MRSA) is susceptible to histone H1 (H1), even in the presence of divalent cations and serum. Through selective evolution and a genome-wide screen of a transposon library, as well as physiological and pharmacological experiments, we elucidated how H1 kills MRSA. We show that H1 first binds to wall teichoic acids with high affinity. Once bound, H1 requires a potentiated membrane and a metabolically active bacterium to permeabilize the membrane and enter the cell. Upon entry, H1 accumulates intracellularly, in close association with the bacterial DNA. Of note, anti-H1 antibodies inhibit neutrophil extracellular trap killing of MRSA. Moreover, H1 colocalizes with bacterial DNA in abscess samples of MRSA-infected patients, suggesting a role for H1 in combating MRSA in vivo.
Keywords: CP: Microbiology; MRSA; Staphylococcus aureus; antimicrobial peptides; antimicrobial resistance; histones; neutrophil extracellular traps; wall teichoic acids.
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests V.J.T. is an inventor on patents and patent applications filed by New York University, which are currently under the commercial license to Janssen Biotech Inc. (JBIO). JBIO provides research funding and other payments associated with an exclusive licensing agreement to V.J.T. The work presented herein is unrelated to these patents.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous